Clinical Trial Update: Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue Virus [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and immune response of two dengue virus vaccines in individuals previously immunized against dengue.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Hemorrhagic Fever

Drugs mentioned

• Dengue virus vaccine candidate A
• Dengue virus vaccine candidate B

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Dengue Hemorrhagic Fever | Phase 1 | Status: COMPLETED